Concurrent Mold, Mycobacterial, and Viral Infections in a Hematopoietic Stem Cell Transplant Recipient Undergoing Lung Transplantation for Graft-Versus-Host Disease
Authors:
- Layan AkkielahLALayan Akkielah
- Wayne LeungWLWayne Leung
- Serena WangSWSerena Wang
- Lili AtaieLALili Ataie
- Anargyros XenocostasAXAnargyros Xenocostas
- Asma SyedASAsma Syed
- Ying-Han R. HsuYHYing-Han R. Hsu
- Michael SilvermanMSMichael Silverman
- Fatimah AlMutawaFAFatimah AlMutawa
- MohammadReza Rahimi ShahmirzadiMSMohammadReza Rahimi Shahmirzadi
Open Access
- 2 March 2026
- journal article
- case report
- Published by MDPI AG in Current Oncology
- Vol. 33 (3) , 145
Abstract
Hematopoietic stem cell transplant (HSCT) recipients are at high risk for opportunistic infections due to profound immunosuppression and graft-versus-host disease (GvHD). Molds and nontuberculous mycobacteria (NTM) pose diagnostic and therapeutic challenges, especially when infections overlap. A 42-year-old woman with prior allogeneic HSCT for acute myeloid leukemia (AML) developed pulmonary infections with Microascus spp. and Mycobacterium chimaera, later complicated by Aspergillus calidoustus and RSV infection. Initial therapy included voriconazole, amphotericin B, and a macrolide-based multidrug regimen for NTM. Modifications were required for drug resistance and hepatotoxicity. Despite partial response, recurrent fungal infection necessitated prolonged antifungal therapy, including adjunctive inhaled amphotericin B and terbinafine. Ultimately, progressive bronchiolitis obliterans prompted bilateral lung transplantation. Explant pathology revealed necrotizing granulomas positive for NTM and Microascus spp. Post-transplant prophylaxis with voriconazole, rifabutin, azithromycin, and inhaled amikacin prevented recurrence, and the patient remained clinically stable at 6-month follow-up. This case illustrates the complexity of managing overlapping mold and NTM infections in HSCT recipients, highlighting the need for individualized, multidisciplinary care. Therapeutic drug monitoring, careful adjustment for drug–drug interactions, and the use of adjunctive inhaled antifungals were critical to achieving a favorable outcome.Keywords
This publication has 33 references indexed in Scilit:
- American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation RecipientsTransplantation and Cellular Therapy, 2025
- Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in LeukaemiaThe Lancet Infectious Diseases, 2022
- Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case reportRespiratory Medicine Case Reports, 2021
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling studyThe Lancet, 2017
- Scopulariopsisand scopulariopsis-like species from indoor environmentsStudies in Mycology, 2017
- Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysisBone Marrow Transplantation, 2015
- Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosisBone Marrow Transplantation, 2012
- Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHDBone Marrow Transplantation, 2011
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell TransplantationJAMA, 2009